ALDH1A1 and neoplasm: Furthermore, tumorigenicity of stem cells coexpressing ALDH1 and CD 133 was studied by Silva et al., who demonstrated that tumor cells coexpressing ALDH1 and CD 133 have highly aggressive phenotype, rapid tumor formation and propagation, worse progression free survival and overall survival in ovarian cancer [123].